Series A
US$4m
Naluri addresses the growing continuous healthcare problem amongst the Asian region with patented, proprietary and evidence based technology
Profile of digital health company Naluri, covering its chronic disease care platform, a stated US$4 million Series A at US$23 million pre-money, earlier Malaysian grants, accelerator programs and planned regional expansion.